Combined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Combined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownNot Applicable

NCT06387407

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of D…

According to published studies, the effects of genetic polymorphisms in the ABCB1 and CES1 genes on the blood concentration of dabigatran are controversial, and…

Location not specified30 participantsStarted 2024-05-01

Treatment: Dabigatran Etexilate 150mg